CM
Castleark Management Portfolio holdings
AUM
$3.33B
1-Year Return
37.9%
This Quarter Return
+7.74%
1 Year Return
+37.9%
3 Year Return
+222.09%
5 Year Return
+481.09%
10 Year Return
+2,703.89%
AUM
$2.45B
AUM Growth
+$4.97M
(+0.2%)
Cap. Flow
-$73M
Cap. Flow
% of AUM
-2.98%
Top 10 Holdings %
Top 10 Hldgs %
39.08%
Holding
313
New
42
Increased
49
Reduced
96
Closed
41
Top Buys
| 1 |
Blackstone
BX
|
$67.5M |
| 2 |
Toll Brothers
TOL
|
$23.6M |
| 3 |
Home Depot
HD
|
$21.7M |
| 4 |
Starbucks
SBUX
|
$21.4M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$16.7M |
Top Sells
| 1 |
DexCom
DXCM
|
$49.7M |
| 2 |
Stryker
SYK
|
$43.9M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
$24M |
| 4 |
NVIDIA
NVDA
|
$21.7M |
| 5 |
Freeport-McMoran
FCX
|
$15.9M |
Sector Composition
| 1 | Technology | 33.98% |
| 2 | Healthcare | 12.67% |
| 3 | Consumer Discretionary | 11.5% |
| 4 | Financials | 11.03% |
| 5 | Industrials | 8.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Agilysys
AGYS
$3.1B
| $4.87M | 0.2% |
44,684
+420
| +0.9% | +$45.8K |
|
127
Champion Homes, Inc.
SKY
$4.43B
| $4.7M | 0.19% |
49,500
+3,200
| +7% | +$304K |
|
|
SUM
128
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $4.61M | 0.19% |
118,178
-4,320
| -4% | -$169K |
|
129
Korn Ferry
KFY
$3.83B
| $4.43M | 0.18% |
58,890
+5,430
| +10% | +$409K |
|
130
Magnolia Oil & Gas
MGY
$4.37B
| $4.41M | 0.18% |
180,730
+96,900
| +116% | +$2.37M |
|
131
CareDx
CDNA
$736M
| $4.37M | 0.18% |
+139,880
| New | +$4.37M |
|
132
Plains All American Pipeline
PAA
$12.1B
| $4.29M | 0.18% |
247,109
| – | – |
|
133
BorgWarner
BWA
$9.53B
| $4.19M | 0.17% |
115,344
+109,770
| +1,969% | +$3.98M |
|
134
Kiniksa Pharmaceuticals
KNSA
$2.65B
| $4.18M | 0.17% |
+167,200
| New | +$4.18M |
|
|
GAP
135
The Gap, Inc.
GAP
$8.83B
| $4.09M | 0.17% |
185,466
-55,100
| -23% | -$1.21M |
|
136
Sweetgreen
SG
$1.06B
| $4.07M | 0.17% |
114,937
+11,717
| +11% | +$415K |
|
137
Halozyme
HALO
$8.76B
| $3.99M | 0.16% |
+69,720
| New | +$3.99M |
|
138
TG Therapeutics
TGTX
$5.11B
| $3.95M | 0.16% |
+168,810
| New | +$3.95M |
|
139
Donnelley Financial Solutions
DFIN
$1.55B
| $3.86M | 0.16% |
58,620
+540
| +0.9% | +$35.5K |
|
|
ITCI
140
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $3.8M | 0.15% |
51,880
-1,900
| -4% | -$139K |
|
141
Crinetics Pharmaceuticals
CRNX
$3.35B
| $3.75M | 0.15% |
+73,340
| New | +$3.75M |
|
142
Brunswick
BC
$4.35B
| $3.74M | 0.15% |
+44,660
| New | +$3.74M |
|
143
iShares US Home Construction ETF
ITB
$3.35B
| $3.68M | 0.15% |
28,950
| – | – |
|
144
Kontoor Brands
KTB
$4.46B
| $3.59M | 0.15% |
43,950
-1,600
| -4% | -$131K |
|
145
Procept Biorobotics
PRCT
$2.26B
| $3.47M | 0.14% |
43,250
-49,990
| -54% | -$4.01M |
|
146
Vericel Corp
VCEL
$1.72B
| $3.3M | 0.13% |
78,020
-64,040
| -45% | -$2.71M |
|
147
Insmed
INSM
$30.7B
| $3.16M | 0.13% |
43,300
+26,640
| +160% | +$1.94M |
|
|
BPMC
148
DELISTED
Blueprint Medicines
BPMC
| $3.14M | 0.13% |
33,990
-5,450
| -14% | -$504K |
|
149
Twist Bioscience
TWST
$1.56B
| $3.14M | 0.13% |
69,520
-87,860
| -56% | -$3.97M |
|
150
Mohawk Industries
MHK
$8.66B
| $3.13M | 0.13% |
+19,460
| New | +$3.13M |
|